State-by-State Price Guide

Medicaid & Ozempic Cost: What You Actually Pay by State (2026)

When Medicaid pays for a GLP-1, your out-of-pocket cost typically drops to $0-$3 a month — but whether you qualify depends entirely on where you live. 33 states cover GLP-1s like Wegovy and Zepbound for weight loss, 3 only fund them for diabetes, and 14 leave you paying cash. Look up your state and find the cheapest legal route if you are stuck.

Julian Caraulani
Julian Caraulani
Lisa Park, RPh
Medically reviewed by Lisa Park, RPh
Published:

See if your plan covers GLP-1s

Pick your carrier — we'll show coverage status and match you with providers that accept it.

Coverage summaries based on common plan formularies. Always confirm with your specific plan — call the member services number on your ID card.

Doesn't qualify for Medicaid?

See the cheapest cash-pay GLP-1 prices

Telehealth providers don't bill Medicaid yet, but these cash-pay programs come in at or under what a non-formulary GLP-1 would cost you out of pocket — sorted cheapest first.

What Medicaid Costs You for a GLP-1: The Numbers

33States Cover Weight Loss
3Diabetes Only
14No Coverage
80M+Medicaid Enrollees

Here is the money math: a GLP-1 that lists for $1,000-$1,350 a month at retail drops to roughly $0-$3 once Medicaid approves it — easily the cheapest path to these drugs if you qualify. By early 2026 most states had added at least one GLP-1 to their weight-loss formulary, up from about 20 states in 2024. The catch is that approval is not automatic: nearly every state gates that low copay behind prior authorization and tight BMI rules.

Your State: Covered (Cheap) or Cash-Pay?

A green "Covered" row means you can land a GLP-1 for a near-zero copay. Click any state for the full price breakdown, prior-auth checklist, and which drugs are on the list. Status reflects fee-for-service Medicaid — managed care plans may price it differently.

StateWeight Loss CoverageNotesDetails
AlabamaLimitedDiabetes onlyView Details
AlaskaCoveredWeight loss coveredView Details
ArizonaCoveredWeight loss coveredView Details
ArkansasNot CoveredExcludedView Details
CaliforniaCoveredWeight loss coveredView Details
ColoradoCoveredWeight loss coveredView Details
ConnecticutCoveredWeight loss coveredView Details
DelawareCoveredWeight loss coveredView Details
FloridaNot CoveredExcludedView Details
GeorgiaNot CoveredExcludedView Details
HawaiiCoveredWeight loss coveredView Details
IdahoNot CoveredExcludedView Details
IllinoisCoveredWeight loss coveredView Details
IndianaCoveredWeight loss coveredView Details
IowaCoveredWeight loss coveredView Details
KansasNot CoveredExcludedView Details
KentuckyCoveredWeight loss coveredView Details
LouisianaCoveredWeight loss coveredView Details
MaineCoveredWeight loss coveredView Details
MarylandCoveredWeight loss coveredView Details
MassachusettsCoveredWeight loss coveredView Details
MichiganCoveredWeight loss coveredView Details
MinnesotaCoveredWeight loss coveredView Details
MississippiNot CoveredExcludedView Details
MissouriLimitedDiabetes onlyView Details
MontanaCoveredWeight loss coveredView Details
NebraskaNot CoveredExcludedView Details
NevadaCoveredWeight loss coveredView Details
New HampshireCoveredWeight loss coveredView Details
New JerseyCoveredWeight loss coveredView Details
New MexicoCoveredWeight loss coveredView Details
New YorkCoveredWeight loss coveredView Details
North CarolinaCoveredWeight loss coveredView Details
North DakotaNot CoveredExcludedView Details
OhioCoveredWeight loss coveredView Details
OklahomaNot CoveredExcludedView Details
OregonCoveredWeight loss coveredView Details
PennsylvaniaCoveredWeight loss coveredView Details
Rhode IslandCoveredWeight loss coveredView Details
South CarolinaNot CoveredExcludedView Details
South DakotaNot CoveredExcludedView Details
TennesseeLimitedDiabetes onlyView Details
TexasNot CoveredExcludedView Details
UtahCoveredWeight loss coveredView Details
VermontCoveredWeight loss coveredView Details
VirginiaCoveredWeight loss coveredView Details
WashingtonCoveredWeight loss coveredView Details
West VirginiaNot CoveredExcludedView Details
WisconsinCoveredWeight loss coveredView Details
WyomingNot CoveredExcludedView Details

Coverage data last verified April 2026. Medicaid policies change frequently — always confirm with your state's Medicaid program directly. Managed care organizations may have different coverage than fee-for-service Medicaid.

How to Confirm Your $0 Copay Before You Order

The table is a starting point, not a guarantee — your individual plan sets the final price. Run these four checks so you know exactly what you will pay at the pharmacy counter before you commit.

Step 1

Phone Member Services and Ask About the Copay

Dial the number on the back of your card and ask two things in plain dollars: 'Is Wegovy or Zepbound on my plan for weight loss, and what is my copay?' Write down the reference number for the call. If you are enrolled in a managed care plan, ask the MCO directly — the state office quotes a different formulary than the plan actually paying your claims.

Step 2

Search the Preferred Drug List Yourself

Every state posts a Preferred Drug List online. Type in 'semaglutide,' 'tirzepatide,' 'Wegovy,' 'Zepbound,' 'Ozempic,' and 'Mounjaro.' A name on the PDL means a covered, low-copay drug — almost always with a prior-auth gate. A name missing from it can still be obtained as a non-preferred exception, though usually at a higher tier.

Step 3

Have Your Prescriber Run a Live Benefits Check

Your doctor's office can pull your exact pricing through their pharmacy benefits system in seconds. This beats every other method because it reads your real plan, not the statewide average. The check spits out your prior-auth requirements, quantity limits, and the precise copay you will owe — typically $0 to $3 on Medicaid.

Step 4

Escalate to the State Pharmacy Benefits Desk

Still getting vague answers? Call your state Medicaid agency and ask for the pharmacy benefits department by name. They can tell you whether weight-loss GLP-1s are funded, the BMI thresholds for approval, and whether a coverage expansion is in the pipeline that could lower your cost soon.

Cheapest Routes When Medicaid Won't Pay

A non-covered state does not mean full retail price. Each option below can knock a GLP-1 from $1,000+ down to a fraction of that — sometimes to zero. Stack the one that fits your situation.

Free Drug via Manufacturer Assistance

Novo Nordisk (Wegovy/Ozempic) and Eli Lilly (Zepbound/Mounjaro) run Patient Assistance Programs that ship the medication at $0 to households that qualify on income. Being turned down by Medicaid can actually strengthen your application. For most low-income patients this is the single cheapest fallback when coverage fails.

View savings programs

The Diabetes-Indication Price Hack

If you carry a type 2 diabetes diagnosis alongside obesity, your prescriber can write Ozempic or Mounjaro for diabetes — a category nearly every state Medicaid pays for at the same near-zero copay. It is the identical molecule; only the billing indication changes, and so does the price you pay.

Ozempic cost guide

Switch MCOs to a Cheaper Formulary

In managed-care states, two plans in the same ZIP code can price the exact same drug worlds apart — one covering Wegovy, the next excluding it. At open enrollment you can move to the MCO with the lower-cost formulary. Call each available plan and compare what they charge before you switch.

Cost center overview

Get It Free Through a Trial

GLP-1 clinical trials supply the study medication at no cost. ClinicalTrials.gov tracks studies actively recruiting, and trials for next-gen compounds (survodutide, orforglipron, retatrutide) are enrolling now. For the right candidate it is effectively a $0 supply with monitoring included.

Next-gen GLP-1 guide

Appealing a Denial to Win the Low Copay

A denial is not the final price. Federal law guarantees every Medicaid member a formal appeal, and a well-documented one frequently flips a rejection into a $0-$3 covered prescription. Here is how to build the appeal that gets you that price.

1

Decode the Denial Letter First

Your denial notice has to spell out the reason and the appeal route. The usual culprits: a BMI just under the threshold, skipped step-therapy requirements, or the drug sitting off the formulary. Pin down the exact reason — every dollar of your appeal effort should aim straight at it.

2

Assemble the Paper Trail

Pull together your full medical history, charted BMI readings, a log of past weight-loss attempts (diets, programs, other meds), records of comorbidities like diabetes, sleep apnea, or hypertension, plus any specialist referrals. The thicker the evidence, the harder it is for the reviewer to keep you off the cheap formulary.

3

Secure a Letter of Medical Necessity

Have your prescriber write a tailored letter arguing why GLP-1 therapy is medically necessary for you in particular. It should rebut the denial reason head-on, cite the clinical evidence behind GLP-1 use for your conditions, and explain why cheaper alternatives won't do the job.

4

File Before the Clock Runs Out

Most states give you 30-60 days to appeal. Put it all in writing and keep copies of everything. Use certified mail or the online portal, and attach the denial reference number, your Medicaid ID, and the full evidence packet so nothing stalls the review.

5

Escalate to a Fair Hearing

If the first appeal fails, request a fair hearing before an administrative law judge — an independent look at your case. You can present evidence, bring witnesses including your doctor, and use an advocate. These requests generally must be filed within 90 days of the appeal denial, so do not sit on it.

Why Your GLP-1 Price Depends on Your Zip Code

What a GLP-1 costs a Medicaid member has almost nothing to do with the drug and everything to do with which state they live in. For years that price was simply "all of it" — most programs excluded anti-obesity medication outright under a 2003 federal rule letting states drop drugs used for "anorexia, weight loss, or weight gain." That carve-out was written long before obesity was treated as a chronic disease with genuinely effective medication, so it quietly kept the cheapest coverage route closed.

That changed fast across 2024-2025. As evidence piled up that GLP-1s cut not just weight but cardiovascular risk, kidney decline, and obesity-related hospital use, the cost argument flipped. Several economic models showed that paying for these drugs could turn cost-neutral for a state within 5-7 years once you net out the savings on diabetes care, heart events, and joint surgeries — which is exactly why so many states have moved them onto the low-copay formulary.

The Budget Math Holding Back a $0 Mandate

The one thing still keeping universal coverage off the table is the sticker shock to state budgets. With roughly 80 million Medicaid enrollees and an estimated 20-30% clinically eligible for GLP-1 therapy, the spend is staggering. Even after the rebates that pull Medicaid's effective cost well below list price, covering everyone eligible has been pegged at $13-26 billion a year. States have to weigh that against every other line item, which is why your access to the cheap copay still arrives one state at a time rather than through a single federal mandate.

Frequently Asked Questions

How much does Ozempic cost on Medicaid?

If your state Medicaid covers it, your copay is usually $0 to $3 a month — far below the roughly $1,000 retail price and cheaper than almost any other route. But there's a catch on the indication: Ozempic is FDA-approved for type 2 diabetes, so it's covered for diabetes in most states. For weight loss your doctor prescribes Wegovy (the weight-loss form of semaglutide) or Zepbound (tirzepatide), and only 36 states currently fund those at that low copay.

How do I find out what I'll actually pay before filling it?

Three fast checks: (1) Call the number on your Medicaid card and ask the copay for Wegovy or Zepbound for weight loss, (2) Search your state's preferred drug list (PDL) online for the drug name, or (3) have your prescriber's office run a live benefits check — it returns your exact copay and prior-auth rules in seconds, which is the most accurate read on your real price.

What's the cheapest option if my state Medicaid won't cover it?

Several routes beat retail: (1) if you also have type 2 diabetes, your doctor can prescribe Ozempic or Mounjaro on the diabetes indication, covered for a near-zero copay almost everywhere, (2) apply for manufacturer assistance (Novo Nordisk PAP or Lilly Cares), which can supply the drug at $0 for qualifying households, (3) check whether a different managed care plan in your state covers it, or (4) compare cash-pay telehealth programs that price below typical non-formulary costs.

Can appealing a denial actually get me the low copay?

Yes, and it often works. Federal law gives every Medicaid member an appeal, with a 30-60 day window depending on the state. Attach a letter of medical necessity from your prescriber documenting your BMI, comorbidities, failed prior treatments, and why GLP-1 therapy is needed. Strong clinical documentation overturns a large share of initial denials — converting full price back to a $0-$3 covered fill.

What hoops must I clear before Medicaid pays the cheap price?

Prior authorization, almost always — even when the drug sits on the preferred list. The typical bar: a documented BMI of 30+ (or 27+ with comorbidities), proof you tried at least one prior weight-management intervention, and no contraindications. Your prescriber's office files the PA. Clear those criteria and your monthly cost drops to the standard Medicaid copay of roughly $0-$3.

Can switching managed care plans lower my GLP-1 cost?

Often, yes. Most Medicaid members are in managed care organizations (MCOs) whose formularies differ from the state's fee-for-service plan and from each other. One MCO may cover Wegovy for weight loss while the plan next door excludes it — a swing from a $0 copay to full cash price. Compare each available MCO's formulary, and switch at open enrollment to the one that covers your drug.

Will a federal rule ever make GLP-1s free under Medicaid everywhere?

Not yet, though pressure is building. Several 2025-2026 federal proposals would require Medicaid to cover FDA-approved anti-obesity drugs, on the logic that covering GLP-1s lowers long-term spending on heart disease, diabetes, and joint replacement. The holdup is the up-front bill — an estimated $13-26 billion a year if every eligible member used one — which keeps the nationwide $0-copay mandate stalled for now.

Find Your Cheapest GLP-1 Price

Medicaid is just one lever on the price. We track every way to pay less for Ozempic, Wegovy, Zepbound, and tirzepatide — line them all up in our cost guides and grab the lowest number.

Disclaimer: Medicaid coverage information is provided for educational purposes and may not reflect the most current state policies. Medicaid programs change frequently. Always verify coverage directly with your state Medicaid agency or managed care plan. GLP-1 Price Tracker is not affiliated with any state Medicaid program or pharmaceutical manufacturer.